Bristol-Myers Squibb Co. (BMY) Tops Q3 EPS by 2c; Affirms FY13 Outlook
Tweet Send to a Friend
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q3 EPS of $0.46, $0.02 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
